Natera, Inc.·4

Jun 16, 9:35 PM ET

Rabinowitz Matthew 4

4 · Natera, Inc. · Filed Jun 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera (NTRA) Exec Chairman Matthew Rabinowitz Sells Shares

What Happened

  • Matthew Rabinowitz, Executive Chairman and Director of Natera, sold a total of 100,000 NTRA shares in open-market transactions (code S) executed on June 12 and June 15, 2026. The combined proceeds were approximately $21.45 million (about $21,447,308). Individual trades report weighted-average prices; the overall sale prices ranged roughly from $208.88 to $219.98 per share.
  • These were sales (liquidations), not purchases or option exercises. The reporting indicates the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Rabinowitz on March 13, 2026, which generally means the sales were pre-planned.

Key Details

  • Transaction dates: June 12, 2026 (50,000 shares, ~$10.70M) and June 15, 2026 (50,000 shares, ~$10.75M).
  • Reported total: 100,000 shares sold for about $21.45 million.
  • Price range (per footnotes): approximately $208.88 to $219.98 per share; many line items report weighted-average prices across narrower ranges.
  • Shares owned after the transactions: not disclosed in the provided filing excerpt.
  • Notable footnotes: F1 — sales were made under a Rule 10b5-1 trading plan (adopted Mar 13, 2026). Multiple other footnotes clarify that several reported prices are weighted averages over a range of execution prices; the holder can provide per-trade breakdowns on request.
  • Filing timeliness: Form 4 filed June 16, 2026, which covers transactions on June 12 and June 15 and was submitted within the standard Form 4 reporting window.

Context

  • Rule 10b5-1 plans allow insiders to schedule trades in advance and are commonly used to avoid accusations of trading on nonpublic information; sales under such plans are generally viewed as pre-planned rather than immediate signals of the insider’s current view.
  • For retail investors: purchases by insiders can be more informative about confidence in future prospects than routine sales; here the filing documents a sizable, planned sale by the company’s Executive Chairman.

Insider Transaction Report

Form 4
Period: 2026-06-12
Rabinowitz Matthew
DirectorEXECUTIVE CHAIRMAN
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-06-12$209.50/sh2,536$531,2802,375,307 total
  • Sale

    Common Stock

    [F1][F3]
    2026-06-12$210.30/sh3,267$687,0482,372,040 total
  • Sale

    Common Stock

    [F1][F4]
    2026-06-12$211.61/sh2,957$625,7372,369,083 total
  • Sale

    Common Stock

    [F1][F5]
    2026-06-12$212.27/sh12,142$2,577,4022,356,941 total
  • Sale

    Common Stock

    [F1][F6]
    2026-06-12$213.43/sh5,034$1,074,3992,351,907 total
  • Sale

    Common Stock

    [F1][F7]
    2026-06-12$214.35/sh5,707$1,223,3012,346,200 total
  • Sale

    Common Stock

    [F1][F8]
    2026-06-12$215.38/sh3,161$680,8152,343,039 total
  • Sale

    Common Stock

    [F1][F9]
    2026-06-12$216.51/sh7,182$1,554,9592,335,857 total
  • Sale

    Common Stock

    [F1][F10]
    2026-06-12$217.32/sh4,276$929,2782,331,581 total
  • Sale

    Common Stock

    [F1][F11]
    2026-06-12$218.17/sh2,133$465,3572,329,448 total
  • Sale

    Common Stock

    [F1][F12]
    2026-06-12$219.36/sh1,605$352,0702,327,843 total
  • Sale

    Common Stock

    [F1][F13]
    2026-06-15$209.83/sh831$174,3722,327,012 total
  • Sale

    Common Stock

    [F1][F14]
    2026-06-15$210.73/sh1,832$386,0572,325,180 total
  • Sale

    Common Stock

    [F1][F15]
    2026-06-15$211.81/sh1,237$262,0082,323,943 total
  • Sale

    Common Stock

    [F1][F16]
    2026-06-15$212.84/sh5,097$1,084,8272,318,846 total
  • Sale

    Common Stock

    [F1][F17]
    2026-06-15$213.88/sh7,836$1,676,0002,311,010 total
  • Sale

    Common Stock

    [F1][F18]
    2026-06-15$214.72/sh10,338$2,219,7472,300,672 total
  • Sale

    Common Stock

    [F1][F19]
    2026-06-15$215.91/sh11,877$2,564,3382,288,795 total
  • Sale

    Common Stock

    [F1][F20]
    2026-06-15$216.81/sh6,741$1,461,5402,282,054 total
  • Sale

    Common Stock

    [F1][F21]
    2026-06-15$217.60/sh3,811$829,2842,278,243 total
  • Sale

    Common Stock

    [F1][F22]
    2026-06-15$218.72/sh400$87,4892,277,843 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    5,000
Footnotes (22)
  • [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
  • [F10]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.95 to $217.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F11]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.96 to $218.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F12]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.26 to $219.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F13]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.27 to $210.22 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F14]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.2850 to $211.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F15]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.30 to $212.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F16]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.32 to $213.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F17]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.32 to $214.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F18]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.32 to $215.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F19]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.32 to $216.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.88 to $209.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F20]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.32 to $217.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F21]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.32 to $218.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F22]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.61 to $218.84 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.88 to $210.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.92 to $211.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.92 to $212.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.92 to $213.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.92 to $214.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.92 to $215.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F9]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.92 to $216.89 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-06-16

Documents

1 file
  • 4
    form4-06162026_090601.xmlPrimary